Target intelligence / Profile preview

SRSF protein kinase 2 pseudogene (SRPK2P)

Target
SRPK2P
Molecular classification
Other
01

Overview

SRSF protein kinase 2 pseudogene (SRPK2P or SRPK2ps) is a nonfunctional genomic segment in humans that shows sequence similarity to the functional SRSF protein kinase 2 gene (SRPK2) but does not encode a protein product. Pseudogenes like SRPK2P generally arise from duplication or retrotransposition events and do not play an active role in biological pathways or serve as protein targets for drugs.

Other names
SRPK2PSRPK2ps
02

Mechanism of action

Pseudogenes have no therapeutic mechanism of action, as they do not code for active proteins.

Beyond the preview

Go deeper on SRSF protein kinase 2 pseudogene (SRPK2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRSF protein kinase 2 pseudogene (SRPK2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call